NCS-356 sodium430440-66-7M69F856TOG(E)-4-(4-Chlorophenyl)-4-hydroxybut-2-enoic acid sodium saltDTXSID101099922-Butenoic acid, 4-(4-chlorophenyl)-4-hydroxy-, sodium salt (1:1), (2E)-Sodium (2E)-4-(4-chlorophenyl)-4-hydroxybut-2-enoateRefChem:1151468FOMSNJCIQOFNOT-IPZCTEOANA-MUNII-M69F856TOGNCS-356 sodium salt hydratesodium;(E)-4-(4-chlorophenyl)-4-hydroxybut-2-enoate
Show more names
NCS-356 hydrate sodium saltγ-p-Chlorophenyl-trans-4-hydroxycrotonate sodium salt hydrate4-(4-Chlorophenyl)-4-hydroxy-2-butenoic acid sodium salt hydrateγ-p-Chlorophenyl-trans-4-hydroxycrotonate hydrate sodium salt, 4-(4-Chlorophenyl)-4-hydroxy-2-butenoic acid hydrate sodium salt
NCGC00094140-01NCS-SODIUM SALT HYDRATE, >= 98% HPLCMLS002153351orb1740221CHEMBL1329790LP00807SMR001230756EU-0100807
Database identifiers
CAS
430440-66-7
PubChem CID
23681234
DTXSID
DTXSID10109992
ChEMBL
CHEMBL1329790
UNII
M69F856TOG
Properties
Computed structural propertiesFilling in
Topological polar surface area
60.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
15
Formal charge
0
Complexity
225
Physicochemical properties
solubility
2 O: · H2O: ≥10mg/mL
color
white to off-white
FDA UNII
69 F856TOG · M69F856TOG
Safety Statements
22 · 22-24/25
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Safety data
safety_code
22-24/25
Chemistry & industry
Applications
UsesNCS-356 Sodium Salt Hydrate is a γ-Hydroxybutyrate (GHB) receptor agonist and a useful building block in the synthesis of various pharmaceuticals.